Total Payments
$41,673
2023 Payments
$14,786
Companies
7
Transactions
41
Medicare Patients
531
Medicare Billing
$45,661
Payment Breakdown by Category
Other$31,206 (74.9%)
Consulting$4,815 (11.6%)
Travel$4,596 (11.0%)
Food & Beverage$1,056 (2.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $31,194 | 10 | 74.9% |
| Consulting Fee | $4,815 | 2 | 11.6% |
| Travel and Lodging | $4,596 | 11 | 11.0% |
| Food and Beverage | $1,056 | 17 | 2.5% |
| Entertainment | $12.08 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $41,125 | 31 | $0 (2023) |
| Mauna Kea Technologies, Inc. | $226.31 | 3 | $0 (2023) |
| Digestive Care, Inc. | $225.63 | 1 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $33.90 | 2 | $0 (2022) |
| Olympus America Inc. | $30.33 | 2 | $0 (2019) |
| PFIZER INC. | $19.01 | 1 | $0 (2018) |
| Avanos Medical | $12.12 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $14,786 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($14,572) |
| 2022 | $19,190 | 13 | Takeda Pharmaceuticals U.S.A., Inc. ($19,156) |
| 2021 | $1,216 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($1,204) |
| 2020 | $6,153 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($6,153) |
| 2019 | $268.04 | 4 | Digestive Care, Inc. ($225.63) |
| 2018 | $59.91 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($40.90) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $830.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/08/2023 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $178.60 | General |
| 05/08/2023 | Mauna Kea Technologies, Inc. | — | Food and Beverage | Cash or cash equivalent | $35.63 | General |
| 03/22/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,153.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/02/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $218.29 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $890.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $493.40 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $140.73 | General |
| Category: INTERNAL MEDICINE | ||||||
| 03/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $116.06 | General |
| Category: INTERNAL MEDICINE | ||||||
| 02/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,083.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $305.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $161.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 01/04/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $161.37 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,153.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/20/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,548.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $974.59 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $138.03 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/15/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $939.81 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Travel and Lodging | In-kind items and services | $173.01 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/03/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Food and Beverage | In-kind items and services | $99.54 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/19/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/17/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,350.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 07/18/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 145 | 198 | $112,709 | $15,198 |
| 2022 | 7 | 144 | 168 | $85,016 | $11,324 |
| 2021 | 8 | 137 | 159 | $109,002 | $11,872 |
| 2020 | 6 | 105 | 121 | $76,675 | $7,267 |
Total Patients
531
Total Services
646
Medicare Billing
$45,661
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 48 | 91 | $32,942 | $4,715 | 14.3% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 15 | 15 | $20,895 | $3,206 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 37 | $19,758 | $2,610 | 13.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 21 | 21 | $15,876 | $1,901 | 12.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 22 | 22 | $9,966 | $1,488 | 14.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $13,272 | $1,278 | 9.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 38 | 59 | $21,358 | $3,154 | 14.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 18 | 18 | $19,908 | $2,477 | 12.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 25 | 26 | $19,656 | $2,147 | 10.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 17 | 18 | $9,612 | $1,483 | 15.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $7,098 | $1,118 | 15.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 15 | 15 | $6,795 | $863.84 | 12.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2022 | 18 | 19 | $589.00 | $81.99 | 13.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 25 | 42 | $12,518 | $2,323 | 18.6% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 12 | 12 | $21,924 | $2,248 | 10.3% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 18 | 18 | $24,894 | $2,205 | 8.9% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 13 | 13 | $17,677 | $1,970 | 11.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 15 | 15 | $15,174 | $1,347 | 8.9% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 12 | 13 | $10,844 | $1,108 | 10.2% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 20 | 23 | $3,333 | $556.02 | 16.7% |
| G0500 | Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | Facility | 2021 | 22 | 23 | $2,638 | $115.92 | 4.4% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 22 | 22 | $35,019 | $2,722 | 7.8% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 15 | 15 | $14,776 | $1,554 | 10.5% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 13 | 13 | $14,918 | $1,307 | 8.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 20 | 29 | $5,646 | $1,061 | 18.8% |
About Robert Carroll
Robert Carroll is a Gastroenterology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457465262.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Robert Carroll has received a total of $41,673 in payments from pharmaceutical and medical device companies, with $14,786 received in 2023. These payments were reported across 41 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($31,194).
As a Medicare-enrolled provider, Carroll has provided services to 531 Medicare beneficiaries, totaling 646 services with total Medicare billing of $45,661. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Chicago, IL
- Active Since 08/18/2006
- Last Updated 06/23/2008
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1457465262
Products in Payments
- GATTEX (Drug) $37,220
- Pertzye (Drug) $225.63
- ENTYVIO (Biological) $119.89
- Entyvio (Biological) $40.90
- XARELTO (Drug) $33.90
- Olympus Biliary Devices (Device) $30.33
- ENFIT (Device) $12.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Chicago
Stephen Hanauer, Md, MD
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
David Rubin
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
Dr. Darren Brenner, M.d, M.D
Gastroenterology — Payments: $1.4M
Gastroenterology $1.4M
Steven Flamm, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Russell Cohen
Gastroenterology — Payments: $834,887
Gastroenterology $834,887
Atman Shah
Gastroenterology — Payments: $766,122
Gastroenterology $766,122